SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001477932-23-007971
Filing Date
2023-10-30
Accepted
2023-10-30 16:15:25
Documents
15
Period of Report
2023-10-29
Items
Item 4.01: Changes in Registrant's Certifying Accountant
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K ipix_8k.htm   iXBRL 8-K 25186
2 LETTER OF HEATON & COMPANY ipix_ex161.htm EX-16.1 2877
  Complete submission text file 0001477932-23-007971.txt   143794

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA ipix-20231029.xsd EX-101.SCH 5735
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE ipix-20231029_lab.xml EX-101.LAB 13171
5 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE ipix-20231029_cal.xml EX-101.CAL 908
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ipix-20231029_pre.xml EX-101.PRE 8259
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE ipix-20231029_def.xml EX-101.DEF 2109
9 EXTRACTED XBRL INSTANCE DOCUMENT ipix_8k_htm.xml XML 3291
Mailing Address 301 EDGEWATER PLACE SUITE 100 WAKEFIELD MA 01880
Business Address 301 EDGEWATER PLACE SUITE 100 WAKEFIELD MA 01880 978-921-4125
Innovation Pharmaceuticals Inc. (Filer) CIK: 0001355250 (see all company filings)

IRS No.: 300565645 | Fiscal Year End: 0630
Type: 8-K | Act: 34 | File No.: 001-37357 | Film No.: 231360415
SIC: 2834 Pharmaceutical Preparations